Connect your AI

Personalis, Inc. PSNL PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

Opko HealthOPK

$33K-50.7%

Labcorp HoldingsLH

$7.8M+1,460%

Bio-Rad LaboratoriesBIO

$100K—

RevvityRVTY

——

Other financials

Income statement

Revenue$15.5M-24.9%

Gross profit$281.0K-96.1%

Operating income-$32.2M-81.7%

Net income-$30.0M-90.7%

EPS (diluted)-$0.29-61.1%

Balance sheet

Cash & equivalents$73.6M+3.7%

Total debt$39.0M-6.2%

Total equity$254.8M+22.9%

Total assets$325.4M+19.1%

Cash flow

Operating cash flow-$22.5M-25.1%

CapEx$3.2M+27.1%

Free cash flow-$25.7M-25.4%

Valuation

Market cap$1.19B+133%

Enterprise value$1.16B+139%

P/S18.4×+12.5×

Profitability

Gross margin13.7%-19.6pp

Operating margin-158.9%-5,457pp

Net margin-148.1%+154pp

FCF margin-131.2%-453pp

Returns & leverage

Return on equity-41.4%-6.7pp

Debt / equity0.2×0.0×

Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Personalis, Inc.'s PP&E sale proceeds?: Personalis, Inc. (PSNL) reported PP&E sale proceeds of $120K in Q1 2026.
What does PP&E sale proceeds mean?: Cash received from selling property, plant, and equipment no longer needed for operations.